Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
PainChek Ltd ( (AU:PCK) ) has issued an update.
PainChek Ltd has announced the application for quotation of 1,343,140 ordinary fully paid securities on the Australian Securities Exchange (ASX), following the exercise of options or conversion of other convertible securities. This move is likely to enhance the company’s financial flexibility and market presence, potentially impacting its operational capabilities and offering opportunities for stakeholders.
More about PainChek Ltd
PainChek Ltd is a company operating in the healthcare industry, focusing on the development and provision of pain assessment technologies. Their primary product is a pain assessment tool that utilizes facial recognition technology to evaluate pain levels in individuals who may have difficulty communicating their pain, such as those with dementia or cognitive impairments.
Average Trading Volume: 4,323,799
Technical Sentiment Signal: Buy
Current Market Cap: A$134.6M
For detailed information about PCK stock, go to TipRanks’ Stock Analysis page.